A clinical guide to assess the role of lower limb extensor overactivity in hemiplegic gait disorders

Stroke

Volumn 30, Issue 3, 1999, Pages 580-585

  Yelnik, Alain ^a,b   Albert, T ^a   Bonan, I ^a   Laffont, I ^a  

^a Physical Medicine and Rehabilitation Department   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Gait; Hemiplegia; Muscle overactivity; Muscle spasticity; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; GAIT DISORDER; HEMIPLEGIA; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SCORING SYSTEM; SITTING; SPASTICITY; STROKE; WALKING;

EID: 0033008025     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.3.580     Document Type: Article

References (34)

1. Knutsson E, Richards C. Different types of disturbed motor control in gait of hemiparetic patients. Brain. 1979;102:405-430.
2. Perry J, Waters RL, Perrin T. Electromyographic analysis of equinovarus following stroke. Clin Orthop Rel Res. 1978;131:47-53.
3. Perry J, Giovan P, Harris LJ, Montgomery J, Azaria M. The determinants of muscle action in the hemiparetic lower extremity. Clin Orthop Rel Res. 1978;131:71-89.
4. O'Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain. 1996;119:1737-1749.
5. Beckerman H, Becher J, Lankhorst GJ, Verbeek AL. Walking ability of stroke patients: efficacy of tibial nerve blocking and a polypropylene ankle foot orthosis. Arch Phys Me. Rehabil. 1996;77:1144-1151.
6. Katrak PH, Cole AMD, Poulos CJ, McCauley JCK. Objective assessment of spasticity, strength and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study. Arch Phys Med Rehabil. 1992;73:4-9.
7. Price R, Lehmann JF, Boswell-Bessette S, Burleigh A, De Lateur BJ. Influence of cryotherapy on spasticity at the human ankle. Arch Phys Med Rehabil. 1993;74:300-304.
8. Abdennebi B, Bougatene B. Selective neurotomies for relief of spasticity focalized to the foot and to the knee flexors. Acta Neurochir. 1996;138: 917-920.
9. Feve A, Decq P, Pilipetti P, Verroust J, Harf A, N'Guyen JP, Keravel Y. Physiological effects of selective tibial neurotomy on lower limb spasticity. J Neurol Neurosurg Psychiatry. 1997;63:575-578.
10. Sindou M, Mertens P. Selective neurotomy of the tibial nerve for treatment of the spastic foot. Neurosurgery. 1988;23:738-744.
11. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic drop foot. J Neurol. 1992;239:375-378.
12. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry. 1995;58:232-235.
13. Hesse S, Lucke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, Mauritz KH. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry. 1994; 57:1321-1234.
14. Pierson SH, Katz DI, Tarsy D. Botulinum toxin: a in the treatment of spasticity functional implications and patient selection. Arch Phys Med Rehabil. 1996;77:717-721.
15. Fugl Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient, I: a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7:13-31.
16. Bajd T, Vodovnik L. Pendulum testing of spasticity. J Biomed Eng. 1984;6:9-16.
17. Wartenberg R. Pendulousness of the legs as a diagnostic test. Neurology. 1951;1:18-24.
18. Denny-Brown D. The basal ganglia and their relation to disorders of movement. London, UK: Oxford University Press; 1962.
19. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540-542.
20. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phy Ther. 1987;67:206-207.
21. Sloan RL, Sinclair E, Thompson J, Taylor S, Pentland B. Inter-rater reliability of the modified Ashworth scale for spasticity in hemiplegic patients. Int J Rehabil Res. 1992;15:158-161.
22. Dietz V, Quintern J, Berger W. Electrophysiological studies of gait in spasticity and rigidity: evidence that altered mechanical properties of muscle contribute to hypertonia. Brain. 1981;104:431-449.
23. Hufschmidt A, Mauritz KH. Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. J Neurol Neurosurg Psychiatry. 1985;48:676-685.
24. Tardieu C, Tabary JC, Tabary C, Tardieu G. Adaptation of connective tissue length to immobilization in the lengthened and shortened positions in cat soleus muscle. J Physiol (Paris). 1982;78:214-220.
25. Fowler V, Canning CG, Carr JH, Shepherd RB. Muscle length effect on the pendulum test. Arch Phys Med Rehabil. 1998;79:169-171.
26. Katz RT, Rovai GP, Brait C, Rymer WZ. Objective quantification of spastic hypertonia: correlation with clinical findings. Arch Phys Med Rehabil. 1992;73:339-347.
27. Thilmann AF, Fellows SJ, Garms E. The mechanism of spastic muscle hypertonus. Brain. 1991;114:233-244.
28. Gracies JM, Wilson L, Gandevia SC, Burke D. Stretched position of spastic muscles aggravates their cocontraction in hemiplegic patients. Ann Neurol. 1997;42:438-439.
29. Bohannon RW. Gait performance of hemiparetic stroke patients: selected variables. Arch Phys Med Rehabil. 1987;68:777-781.
30. Bohannon RW, Andrews AW. Correlation of knee extensor muscle torque and spasticity with gait speed in patients with stroke. Arch Phys Med Rehabil. 1990;71:330-333.
31. Sahrmann SA, Norton BJ. The relationship of voluntary movement to spasticity in the upper motor neuron syndrome. Ann Neurol 1977;2: 460-465.
32. Steinberg FU, Ferguson KL. Effect of dantrolene sodium on spasticity associated with hemiplegia. J Am Geriatr Soc. 1975;23:70-73.
33. Hinderer SR, Gupta S. Functional outcome measures to assess interventions for spasticity. Arch Phys Med Rehabil. 1996;77:1083-1089.
34. Filipetti P, Decq P, Feve A, Kolanowski E, Deltombe T. Blocs moteurs périphériques et restauration fonctionnelle: a propos de 202 blocs. Ann Réadaptation Med Phys. 1998;41:23-30.